EMA Confirms Fast-Track EUA-Style Review For Molnupiravir In COVID-19

Rolling Review Is Under Way But Could Take Some Time

 
• By Ian Schofield

The EU regulator says it is taking the emergency use route for molnupiravir because of the worrying rise in coronavirus infections and deaths.

Immunological system, antibodies attacking the virus covid-19.
Several potential COVID-19 treatments are under review in the EU • Source: Alamy

More from Europe

More from Geography